ナルミヤ コウスケ   NARUMIYA Kosuke
  成宮 孝祐
   所属   医学部 医学科(東京女子医科大学病院)
   職種   非常勤講師
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 Prognostic Impact of Pretreatment Serum CYFRA Status in 1047 Patients with Esophageal Squamous Cell Carcinoma Who Underwent Radical Resection: A Japan Esophageal Society Promotion Research.
掲載誌名 正式名:Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
略  称:Ann Thorac Cardiovasc Surg
ISSNコード:21861005/13411098
掲載区分国内
巻・号・頁 28(3),pp.163-170
著者・共著者 ISHIOKA Nobuki, SUZUKI Takashi, YAJIMA Satoshi, MURAKAMI Kentaro, OHKURA Yu, FUKUDA Takashi, YAGI Koichi, OKAMURA Akihiko, HOSHINO Isamu, KUNISAKI Chikara, NANAJIMA Yasuaki, NARUMIYA Kosuke, OGAWA Ryo, SHIMADA Hideaki
発行年月 2022/06
概要 PURPOSE:The prognostic significance of pretreatment serum C-terminus of cytokeratin 19 (CYFRA21-1, CYFRA) status was evaluated in the patients with surgically treated esophageal squamous cell carcinoma.METHODS:A total of 1047 patients with surgically treated esophageal cancer were enrolled in a multi-institutional study promoted by the Japanese Esophageal Society. This study included an up-front surgery group (n = 412), a neoadjuvant chemotherapy (NAC) group (n = 486), and a neoadjuvant chemoradiation/radiation therapy (NACRT/RT) group (n = 149). The pretreatment CYFRA status was analyzed to assess prognostic significance using multivariate analysis according to treatment modalities.RESULTS:The CYFRA-positive group was significantly associated with deep tumor. Univariate analysis showed that the overall survival of the CYFRA-positive group was significantly worse than that of the CYFRA-negative group, but the difference was not significant in the multivariate analysis. CYFRA was an independent risk factor for poor prognosis just in the NACRT/RT group.CONCLUSIONS:The CYFRA-positive group was associated with deep tumor and poor survival. Pretreatment CYFRA was not an independent risk factor for poor prognosis in the up-front surgery group or NAC group. It was an independent risk factor for poor prognosis just in the NACRT/RT group.
DOI 10.5761/atcs.oa.21-00195
PMID 34690219